(Q36739366)

16 August 2017

RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model (English)

1 reference

16 August 2017

Wujiang Liu

1

1 reference

16 August 2017

Barry R Deyoung

2

1 reference

16 August 2017

Xiaohong Chen

3

1 reference

16 August 2017

David P Evanoff

4

1 reference

16 August 2017

Yi Luo

5

1 reference

16 August 2017

26 December 2007

1 reference

16 August 2017

Journal of Autoimmunity

1 reference

16 August 2017

30

1 reference

16 August 2017

4

1 reference

16 August 2017

257-265

1 reference

The role of the innate immune response in autoimmune disease

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Interstitial cystitis and systemic autoimmune diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Balancing autoaggressive and protective T cell responses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Biological therapies for inflammatory bowel disease: research drives clinics.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

RDP-58 (SangStat Medical).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Rational design and development of RDP58.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Diagnosis and treatment of urinary tract complications in Crohn's disease: an experience over 15 years

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Mast cell involvement in interstitial cystitis: a review of human and experimental evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Inflammatory cell types and clinical features of interstitial cystitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Constitutive class I-restricted exogenous presentation of self antigens in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Role of the immune response in interstitial cystitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Cellular Immunity in Interstitial Cystitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Autoantibodies and interstitial cystitis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Lower urinary tract symptoms in female patients with rheumatoid arthritis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Severe interstitial cystitis associated with Sjögren's syndrome

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Interstitial cystitis and Sjögren's syndrome

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Bladder hypersensitivity of interstitial cystitis complicated by allergic diseases

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Estrogen and neuroinflammation

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Autoantibodies in interstitial cystitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2441447

Evidence for urothelial cell activation in interstitial cystitis

5 September 2018

1 reference

12 December 2020

Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study

1 reference

12 December 2020

Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis

1 reference

12 December 2020

Voiding dysfunction in women with systemic lupus erythematosus

1 reference

12 December 2020

[Physiopathologic relationship between interstitial cystitis and rheumatic, autoimmune, and chronic inflammatory diseases]

1 reference

12 December 2020

Panic disorder, interstitial cystitis, and mast cells

1 reference

12 December 2020

Genitourinary complications of inflammatory bowel disease

1 reference

12 December 2020

Sjögren's syndrome in patients with interstitial cystitis

1 reference

12 December 2020

Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis

1 reference

12 December 2020

Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis

1 reference

12 December 2020

Obstructive uropathy due to interstitial cystitis in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis

1 reference

12 December 2020

Urine autoantibodies in interstitial cystitis

1 reference

12 December 2020

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

1 reference

12 December 2020

Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin

1 reference

12 December 2020

Bladder dysfunction in type 2 diabetic patients

1 reference

12 December 2020

The enigma of interstitial cystitis--an autoimmune disease?

1 reference

12 December 2020

SLE with interstitial cystitis, reversible hydronephrosis and intestinal manifestations

1 reference

12 December 2020

Abnormal urothelial HLA-DR expression in interstitial cystitis

1 reference

12 December 2020

10.1016/J.JAUT.2007.10.005

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference